| RS2065899494 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS2065902096 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Syndromic X-linked intellectual disability Lubs type, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065902916 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065903080 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065904037 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065904589 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2065905008 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2065907079 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS2065907185 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065908727 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065911287 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2065911518 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2065911737 |
BBS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 4 |
| RS2065913161 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS2065913795 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2065914451 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065917262 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2065919863 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Neurodevelopmental delay |
| RS2065920670 |
MECP2
|
Health Risk |
Likely pathogenic |
Autism, susceptibility to |
| RS2065924353 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe neonatal-onset encephalopathy with microcephaly, Rett syndrome |
| RS2065924675 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS2065925520 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2065925648 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS2065928811 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS2065932064 |
BBS4
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2065932114 |
BBS4
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 4, BBS4-related disorder |
| RS2065932944 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Bardet-Biedl syndrome |
| RS2065933012 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2065933350 |
SH3KBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2065935510 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065935636 |
MECP2
|
Health Risk |
Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065938100 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome 4 |
| RS2065944203 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065947222 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Inborn genetic diseases |
| RS2065950974 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Rett syndrome |
| RS2065959942 |
COL13A1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 19, Congenital myasthenic syndrome 19 |
| RS2065960258 |
BPTF
|
Health Risk |
Likely pathogenic |
— |
| RS2065960775 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS2065962813 |
MITF
|
Health Risk |
Pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2065987178 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS2065988707 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2065989620 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Intellectual disability |
| RS2066011284 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066011417 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066030589 |
FOXP3
|
Health Risk |
Likely pathogenic |
— |
| RS2066032846 |
FOXP3
|
Health Risk |
Likely pathogenic |
Hydrops fetalis, Hydrops fetalis |
| RS2066044949 |
FOXP3
|
Health Risk |
Pathogenic/Likely pathogenic/Likely risk allele |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Neurodevelopmental disorder |
| RS2066051319 |
MYRF
|
Health Risk |
Likely pathogenic |
Congenital diaphragmatic hernia, Heart |
| RS2066053673 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2066062676 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
COL4A5-related disorder, Nonpapillary renal cell carcinoma |
| RS2066064057 |
COL4A5
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2066064533 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2066069145 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066070056 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066070104 |
COL4A5
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2066083033 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2066088072 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2066089464 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2066099798 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066101487 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066119604 |
AVP
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurohypophyseal diabetes insipidus, Neurohypophyseal diabetes insipidus |
| RS2066130986 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066132105 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066138676 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066139158 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2066140289 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066155612 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2066157933 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066157974 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2066158230 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066158359 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066158802 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066158952 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066159719 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2066160116 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2066160245 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2066169270 |
TTN
|
Health Risk |
Pathogenic |
Early-onset myopathy with fatal cardiomyopathy, TTN-related myopathy |
| RS2066183255 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066188778 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066189282 |
COL4A5
|
Health Risk |
Pathogenic |
Alport syndrome, Alport syndrome |
| RS2066227699 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066231013 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066237678 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066248439 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2066264379 |
MITF
|
Health Risk |
Pathogenic |
— |
| RS2066264802 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Tietz syndrome |
| RS2066265350 |
MITF
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Waardenburg syndrome type 2A |
| RS2066273571 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2066274585 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066284895 |
ZNF699
|
Health Risk |
Pathogenic |
DEGCAGS syndrome, DEGCAGS syndrome |
| RS2066292405 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS2066300090 |
TCTN1
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2066302424 |
MYRF
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS2066302717 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2066319871 |
HAMP
|
Health Risk |
Pathogenic |
Hemochromatosis type 2B, Hemochromatosis type 2B |
| RS2066339336 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066342176 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066342908 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2066373952 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS2066382188 |
MYRF
|
Health Risk |
Likely pathogenic |
Heart, malformation of |